You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenovirus Vector

Showing 1 - 25 of 924
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Singapore (Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation)

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation
  • Singapore, Singapore
    National University Hospital
Jan 29, 2023

Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)

Completed
Has Results
  • Ebola Virus
  • cAd3-EBO S vaccine
  • Kampala, Uganda
    Makerere University-Walter Reed Project
Nov 10, 2022

Herpes Zoster Trial in Halifax (Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV), Zoster Vaccine Recombinant,

Not yet recruiting
  • Herpes Zoster
  • Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV)
  • +5 more
  • Halifax, Canada
    Canadian Center for Vaccinology
Aug 6, 2023

COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
  • Taizhou, Jiangsu, China
    Taixing City center for Disease Control and Prevention
Oct 28, 2022

SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

Not yet recruiting
  • Metabolic Associated Fatty Liver Disease
  • Recombinant protein vaccine and adenovirus vector vaccine
  • (no location specified)
Feb 12, 2023

Chronic Liver Disease Trial in Hong Kong (BNT162b2, CoronaVac, AZD1222)

Recruiting
  • Chronic Liver Disease
  • BNT162b2
  • +2 more
  • Hong Kong, Hong Kong
    Humanity & Health Medical Group Limited
Aug 1, 2022

COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

Active, not recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
  • Yancheng, Jiangsu, China
    Funing Center for Disease Control and Prevention
Oct 28, 2022

Marburg Virus Disease Trial in Silver Spring (cAd3-Marburg vaccine)

Completed
Has Results
  • Marburg Virus Disease
  • cAd3-Marburg vaccine
  • Silver Spring, Maryland
    WRAIR Clinical Trials Center,
Aug 9, 2022

COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For

Recruiting
  • COVID-19
  • Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 1, 2023

COVID-19 Trial (1 Nebulized inhalation for booster groups, 2 Nebulized inhalation for booster groups, 3 Nebulized inhalation for

Recruiting
  • COVID-19
  • 1 Nebulized inhalation for booster groups
  • +23 more
  • Xiangxi, Hunan, China
    CDC of of Luxi County, Xiangxi Tujia and Miao Autonomous Prefect
Oct 24, 2022

SARS-CoV Infection Trial in India (BBV154 Vaccine, Placebo)

Completed
  • SARS-CoV Infection
  • BBV154 Vaccine
  • Placebo
  • Patna, Bihar, India
  • +3 more
Aug 17, 2022

Covid19 Trial in Brisbane (SC-Ad6-1)

Recruiting
  • Covid19
  • SC-Ad6-1
  • Brisbane, Queensland, Australia
    Tetherex Study Site
Apr 29, 2022

COVID-19 Trial (Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector), Bivalent Recombinant COVID-19 Vaccine

Not yet recruiting
  • COVID-19
  • Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector)
  • +2 more
  • (no location specified)
Jul 5, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

COVID-19 Trial (Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH), Placebo)

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH)
  • Placebo
  • (no location specified)
Nov 19, 2021

COVID-19 Trial in Nanjing (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation, Recombinant Novel

Recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincal Center for Disease Control and Prevention
Jul 27, 2021

Prostate Cancer Trial in Birmingham (AdNRGM)

Completed
  • Prostate Cancer
  • AdNRGM
  • Birmingham, West Midlands, United Kingdom
    Queen Elizabeth Hospital Birmingham, University Hospitals Birmin
Nov 2, 2021

Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:

Terminated
  • Transitional Cell Carcinoma
  • +3 more
  • CG0070 Adenovirus Vector
  • Control Arm: Quadruple Choice
  • Phoenix, Arizona
  • +6 more
Apr 12, 2021

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    WCCT Global, Inc.
Sep 19, 2022

COVID-19, SARS-CoV2 Infection Trial in Hamilton (Ad5-triCoV/Mac, ChAd-triCoV/Mac)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Ad5-triCoV/Mac
  • ChAd-triCoV/Mac
  • Hamilton, Ontario, Canada
    McMaster University Medical Centre
Jun 15, 2022

Covid19 Trial in Caba, Capital Federal (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV))

Recruiting
  • Covid19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV)
  • Caba, Buenos Aires, Argentina
  • +3 more
Sep 14, 2021

Participants in Preventive HIV Vaccine Studies in Uganda

Completed
  • HIV Infections
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    COVID-19 Trial (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant COVID-19 vaccine (adenovirus type

    Not yet recruiting
    • COVID-19
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
    • Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH)
    • (no location specified)
    Jan 11, 2022

    Severe Haemophilia A Trial in United Kingdom (valoctocogene roxaparvovec)

    Active, not recruiting
    • Severe Haemophilia A
    • valoctocogene roxaparvovec
    • Basingstoke, United Kingdom
    • +5 more
    Feb 22, 2022

    COVID-19 Trial in Wuhan (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector))

    Completed
    • COVID-19
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
    • Wuhan, Hubei, China
      Hubei Provincial Center for Disease Control and Prevention
    Aug 2, 2021